Want to see HK:1789 full AI Analyst Report?
1789 Stock Chart & Stats
HK$5.91
-HK$0.05(-1.15%)
At close: 4:00 PM EST
HK$5.91
-HK$0.05(-1.15%)
Day’s Range― - ―
52-Week RangeHK$4.75 - HK$7.24
Previous CloseN/A
Volume3.85M
Average Volume (3M)4.30M
Market Cap
HK$5.74B
Enterprise ValueHK$5.02B
Total Cash (Recent Filing)HK$1.47B
Total Debt (Recent Filing)HK$144.79M
Price to Earnings (P/E)14.7
Beta1.09
Next Earnings
Sep 02, 2026EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend Yield1.26%
Share Statistics
EPS (TTM)0.30
Shares Outstanding1,124,616,700
10 Day Avg. Volume3,969,892
30 Day Avg. Volume4,297,109
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)1.97
Price to Sales (P/S)3.87
P/FCF Ratio18.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.40Price Target Upside42.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.36
Revenue Forecast (FY)HK$1.67B
Bulls Say, Bears Say
Bulls Say
High ProfitabilitySustained high gross and operating margins indicate structural pricing power and efficient manufacturing for orthopaedic implants. Such profitability supports durable internal funding for R&D, distribution expansion and buffers versus pricing pressure, preserving long-term earnings quality.
Very Low LeverageAn exceptionally conservative balance sheet with minimal debt provides financial flexibility to fund capex, new product development or geographic expansion without refinancing risk. Low interest burden enhances resilience through demand cycles and supports strategic optionality.
Positive Free Cash FlowConsistent FCF generation that materially covers earnings indicates the business converts profits into spendable cash for reinvestment, dividends or buybacks. Steady FCF growth supports sustainable capital allocation and validates underlying earnings quality over time.
Bears Say
Cash-Flow VolatilityMaterial swings in operating cash flow across years reduce predictability of funding for growth and shareholder returns. Volatility suggests working-capital sensitivity or timing issues in receivables/tenders, increasing execution risk and the need for larger liquidity buffers.
Uneven Revenue GrowthThe company shows episodic revenue performance rather than steady expansion, reflecting sensitivity to procedure volumes, tenders and surgeon adoption. This uneven growth complicates long-term capacity planning, R&D payback and makes margin leverage less predictable.
ROE Below Historical PeakAlthough ROE has recovered, it remains under prior peak levels, implying capital is not yet being deployed as efficiently as before. Persistent gap to peak ROE can limit long-term shareholder return potential unless growth or operating efficiency improves.
AK Medical Holdings Ltd. News
1789 FAQ
What was AK Medical Holdings Ltd.’s price range in the past 12 months?
AK Medical Holdings Ltd. lowest stock price was HK$4.75 and its highest was HK$7.24 in the past 12 months.
What is AK Medical Holdings Ltd.’s market cap?
AK Medical Holdings Ltd.’s market cap is HK$5.74B.
When is AK Medical Holdings Ltd.’s upcoming earnings report date?
AK Medical Holdings Ltd.’s upcoming earnings report date is Sep 02, 2026 which is in 59 days.
How were AK Medical Holdings Ltd.’s earnings last quarter?
AK Medical Holdings Ltd. released its earnings results on Mar 25, 2026. The company reported HK$0.185 earnings per share for the quarter, beating the consensus estimate of HK$0.173 by HK$0.012.
Is AK Medical Holdings Ltd. overvalued?
According to Wall Street analysts AK Medical Holdings Ltd.’s price is currently Undervalued.
Does AK Medical Holdings Ltd. pay dividends?
AK Medical Holdings Ltd. pays a Annually dividend of HK$0.118 which represents an annual dividend yield of 1.26%. See more information on AK Medical Holdings Ltd. dividends here
What is AK Medical Holdings Ltd.’s EPS estimate?
AK Medical Holdings Ltd.’s EPS estimate is 0.2.
How many shares outstanding does AK Medical Holdings Ltd. have?
AK Medical Holdings Ltd. has 1,124,616,700 shares outstanding.
What happened to AK Medical Holdings Ltd.’s price movement after its last earnings report?
AK Medical Holdings Ltd. reported an EPS of HK$0.185 in its last earnings report, beating expectations of HK$0.173. Following the earnings report the stock price went up 2.634%.
Which hedge fund is a major shareholder of AK Medical Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1789
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AK Medical Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.55%
12-Months-Change
Fundamentals
Return on Equity
12.01%
Trailing 12-Months
Asset Growth
14.93%
Trailing 12-Months
Company Description
AK Medical Holdings Ltd.
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
1789 Stock 12 Month Forecast
Average Price Target
HK$8.40
▲(42.13% Upside)
Technical Analysis
MicroPort Scientific
―
LifeTech Scientific Corporation
―
MicroPort CardioFlow Medtech Corp.
―
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
―
Venus Medtech (Hangzhou), Inc. Class H
―
Options Prices
Currently, No data available
---